Sari Kaplan

Sari Kaplan is a seasoned legal professional with extensive experience in providing legal counsel in the healthcare and biotechnology sectors. Currently serving as Director, Senior Counsel at Abbott since April 2022, Sari Kaplan focuses on compliance, risk management, and legal issues related to the Heart Failure business, with expertise in FDA regulations, fraud laws, and digital health. Prior to Abbott, Sari Kaplan worked at Genentech as Corporate Counsel in the Healthcare Law Group, advising on FDA promotional matters and compliance strategies. Previous roles include Senior Associate at Hogan Lovells, where Sari Kaplan provided counsel on FDA compliance for pharmaceutical and biotechnology clients, and Associate at Arnall Golden Gregory LLP, specializing in FDA and healthcare regulatory compliance. Sari Kaplan's educational background includes a BA with Honors from Stanford University and a J.D. from Emory University.